Ari Bousbib - Quintiles IMS Insider

Quintiles IMS Holdings Inc -- USA Stock  

USD 103.03  1.21  1.19%


Mr. Ari Bousbib is a Chairman of the Board, President, Chief Executive Officer of the Company. He assumed this position in October 2016 following the Merger of Quintiles and IMS Health. From 2010 until the Merger, Mr. Bousbib served as chairman and CEO of IMS Health. In 2014, he led the successful IPO of the company. Prior to joining IMS Health, Mr. Bousbib spent 14 years at United Technologies Corporationrationration, an aerospace, defense and building industries company. From 2008 until 2010, he served as President of UTCs Commercial Companies, including Otis Elevator Company, Carrier Corporationrationration, UTC Fire Security and UTC Power Inc. From 2002 until 2008, Mr. Bousbib was President of Otis, and from 2000 to 2002 he served as its Chief Operating Officer. Previously, Mr. Bousbib was a partner at Booz Allen Hamilton. Mr. Bousbib currently serves on the board of directors of The Home Depot, Inc. and is a member of the Harvard Medical School Health Care Policy Advisory Council. He previously served on the board of directors of Best Buy, Inc. and was appointed by the President of the United States to serve on the Presidents Commission on White House Fellowships
Age: 55  Director Since 2016  MBA    
Bousbib holds a MS Degree in Mathematics and Mechanical Engineering from the Ecole Superieure des Travaux Publics, Paris, and an M.B.A. from Columbia University.

Ari Bousbib Latest Insider Activity

Ari Bousbib over two weeks ago via Macroaxis 
IMS Health exotic insider transaction detected

Management Efficiency

The company has return on total asset of 4.12 % which means that for every 100 dollars spent on asset it generated profit of $4.12. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 2.25 % implying that it made 2.25 on every $100 invested by shareholders.
The company has accumulated 8.97 B in total debt with debt to equity ratio (D/E) of 115.3 implying that the company may be unable to produce cash to meet its debt commitments. Quintiles IMS Holdings Inc has Current Ratio of 1.21 implying that it may have difficulties to pay its interest payments when they become due.

Similar Executives

Showing few of many executives


Christopher CoughlinAllergan plc
Jill SmithEndo International plc
Nesli BasgozAllergan plc
Terrence KearneyVertex Pharmaceuticals Incorpor
Alice SchwartzBio Rad Laboratories Inc
Arthur HigginsEndo International plc
Sally BlountAbbott Laboratories
James BloemAllergan plc
Ron TaylorAllergan plc
Christopher BodineAllergan plc
Todd SisitskyEndo International plc
Robert AlpernAbbott Laboratories
Adriane BrownAllergan plc
Louis DrapeauBio Rad Laboratories Inc
Fred WeissAllergan plc
Bruce SachsVertex Pharmaceuticals Incorpor
Ronald TaylorAllergan plc
Peter McDonnellAllergan plc
William MontagueEndo International plc
Michael HyattEndo International plc
Deborah NeffBio Rad Laboratories Inc

Entity Summary

Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. Quintiles IMS Holdings Inc (Q) is traded on New York Stock Exchange in USA. It is located in NORTH CAROLINA, U.S.A and employs 36,100 people. Quintiles IMS is listed under Business Services category by Fama And French industry classification.

Did you try this?

Run Price Transformation Now

Price Transformation

Use Price Transformation models to analyze depth of different equity instruments across global markets
Hide  View All  Next  Launch Price Transformation
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Quintiles IMS Holdings Inc to your portfolio

Top Management

Quintiles IMS Holdings Leadership Team
Ari Bousbib, Director, MBA
Michael Evanisko, Director
Leonard Schaeffer, Director
James Erlinger, President, MBA
John Danhakl, Director, MBA
Michael McDonnell, President
Kevin Gordon, COO
John Leonard, Director, Ph.D
James Fasano, Director, MBA
Jonathan Coslet, Director, MBA
Anand MD, Executive
Christopher Gordon, Director, MBA
John Connaughton, Director, MBA
Haiyuan Lo, Director
Dennis Gillings, Chairman, Ph.D
Todd Sisitsky, Director, MBA
Jack Greenberg, Director, CPA
Thomas Pike, CEO
Fred Cohen, Director
Richard Staub, President
MRCA MBBS, Executive
Mireille Gillings, Director, Ph.D
Richard Relyea, Director
Ronald Rittenmeyer, Director, MBA
Kevin Knightly, President

Stock Performance

Quintiles IMS Performance Indicators